(Updates)
** Shares of telehealth firms Hims & Hers Health fall 5.7% to $15.14, LifeMD fall ~5% to $5.18, Teladoc Health down 1.2% at $7.23 in early trading
** Eli Lilly has begun selling single-dose vials of its weight-loss drug Zepbound in the U.S. through its LillyDirect website
** Zepbound's 2.5 milligram and 5 mg vials will be available at respective list prices of $399 and $549 for a month's supply - LLY
** HIMS offers compounded GLP-1 weight-loss injections at $199 per month
** "With Lilly now offering Zepbound at a near 50% discount to its autoinjector formulation through LillyDirect, (Zepbound) compounders are likely to be challenged more forcefully," said BMO Capital Markets analyst Evan Seigerman
** Lilly had sent
cease-and-desist letters
to U.S. healthcare providers earlier this month to stop promotion of compounded versions of its weight-loss and diabetes drugs
** Including session's moves, HIMS stock up ~72%, TDOC down ~66%, LFMD down ~38% YTD
(Reporting by Mariam Sunny in Bengaluru)
((Mariam.ESunny@thomsonreuters.com;))
Comments